Health
FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer – News-Medical.Net
The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss…
Reviewed by Emily Henderson, B.Sc.Nov 23 2020
The U.S. Food and Drug Administration has request for emergency use authorization a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.
The FDA recognizes that transparency and dialogue are critical for the public to have confidence in COVID-19 vaccines. I want…
-
General21 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General23 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
General14 hours agoAustralia’s Diamonds defeat South Africa’s Proteas 65-42 in third netball Test
-
Business23 hours agoTop brokers name 3 ASX shares to buy next week 12 October 2025